位置:成果数据库 > 期刊 > 期刊详情页
黄芩苷协同头孢唑啉对金黄色葡萄球菌生物膜的体外研究
  • ISSN号:1672-9463
  • 期刊名称:中国现代医药杂志
  • 时间:2012.12.12
  • 页码:1-3
  • 分类:R181.32[医药卫生—流行病学;医药卫生—公共卫生与预防医学]
  • 作者机构:[1]广西医科大学第一附属医院呼吸疾病研究所,广西南宁530021
  • 相关基金:国家自然科学基金资助项目(81060002)教育部博士点基金项目(20070598007)广西壮族自治区卫生厅自筹基金课题(Z2010334)广西壮族自治区中医药管理局基金课题(gzzc1138)广西教育厅课题(桂教2011LX092)
  • 相关项目:黄芩活性成分对金黄色葡萄球菌生物膜干预作用及其机制的研究
中文摘要:

目的分析ICU与非ICU患者医院下呼吸道感染病原菌分布和耐药性,为提高临床抗感染治疗水平提供依据。方法回顾性分析3年ICU与非ICU医院下呼吸道感染病原菌分布及其耐药性,对其进行统计分析。结果医院下呼吸道感染ICU组以非发酵菌为主,占总病原菌38.2%,非ICU组以肠杆菌科细菌及真菌为主,分别占总病原菌29.2%、32.3%;共分离出病原菌514株,革兰阴性杆菌318株占61.9%,其次为真菌166株占32.3%,革兰阳性球菌30株占5.8%;ICU组感染鲍氏不动杆菌及嗜麦芽寡养单胞菌的检出率高于非ICU组,非ICU组感染真菌高于ICU组;ICU组和非ICU组鲍氏不动杆菌对常用抗菌药物耐药率分别为环丙沙星87.8%、62.9%,哌拉西林/他唑巴坦53.2%、22.9%,头孢他啶91.8%、60.9%,亚胺培南/西司他丁32.7%、25.7%,头孢哌酮/舒巴坦12.2%、6.0%。结论临床应根据药敏结果合理使用抗菌药物,可减少耐药菌株产生。

英文摘要:

OBJECTIVE To analyze the distribution and drug resistance of the pathogens causing lower respiratory tract infections in the ICU and non-ICU patients so as to provide basis for improving the leuel of auti-imfeltion therapg. METHODS The distribution and drug resistance of the pathogens causing lower respiratory tract infections in the ICU and non-ICU in three years were retrospectively analyzed and then were taken for statistical analysis. RESULTS The main pathogens causing nosocomial lower respiratory tract infections were non-fermenting bacteria in ICU, accounting for 38.2 %;Enterobacteriaceae and fungi were the main pathogens in the non-ICU, accounting for 29.2% and 32.3%. Totally 514 strains of pathogens were isolated, including 318 (61.9%) strains of gram-negative bacilli, 166 (32. 3%) strains of fungi, and 30 (5.8%) strains of gram-positive coccci. The number of the cases with Acinetobacter infections and Stenotrophomonas maltophilia infections in the ICU was more than that in the non-ICU, but the cases with fungal infections in the non-ICU were more than that in the ICU. The drug resistance rates of A. baumannii strains in the ICU and non-ICU to ciprofloxacin were 87.8% and 62.9%, piperacillin-tazobaetam (53. 2% and 2. 9% ), ceftazidime (91.8% and 60. 9%) ,imipenem-cilastatin (32.7% and 25.7%) , cefoperazone-snlbactam (12.2% and 6.0%), and meropenem (42.9% and 8.6%). CONCLUSION Only in this way to use antibiotics based on the result of the drug susceptibility testing can the drug resistant strains be reduced.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国现代医药杂志》
  • 主管单位:中国航天科技集团公司
  • 主办单位:北京航天总医院
  • 主编:王建国
  • 地址:北京市丰台区万源北路7号
  • 邮编:100076
  • 邮箱:Bixiangz2002@263.net
  • 电话:010-68383759
  • 国际标准刊号:ISSN:1672-9463
  • 国内统一刊号:ISSN:11-5248/R
  • 邮发代号:82-958
  • 获奖情况:
  • 国内外数据库收录:
  • 被引量:15301